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Abstract
Background: It is unclear how modifications in the way to calculate serum creatinine (sCr) increase and in the cut-off
value applied, influences the prognostic value of Acute Kidney Injury (AKI). We wanted to evaluate whether these
modifications alter the prognostic value of AKI for prediction of mortality at 3 months, 1 and 2 years.
Methods: We prospectively included 195 septic patients and evaluated the prognostic value of AKI by using three
different algorithms to calculate sCr increase: either as the difference between the highest value in the first 24 h after
ICU admission and a pre-admission historical (ΔHIS) or an estimated (ΔEST) baseline value, or by subtracting the ICU
admission value from the sCr value 24 h after ICU admission (ΔADM). Different cut-off levels of sCr increase (0.1, 0.2, 0.3,
0.4 and 0.5 mg/dl) were evaluated.
Results: Mortality at 3 months, 1 and 2 years in AKI defined as ΔADM> 0.3 mg/dl was 48.1 %, 63.0 % and 63.0 % vs
27.7 %, 39.8 % and 47.6 % in no AKI respectively (OR(95%CI): 2.42(1.06-5.54), 2.58(1.11-5.97) and 1.87(0.81-4.33); 0.3 mg/dl
was the lowest cut-off value that was discriminatory. When AKI was defined as ΔHIS > 0.3 mg/dl or ΔEST > 0.3 mg/dl,
there was no significant difference in mortality between AKI and no AKI.
Conclusions: The prognostic value of a 0.3 mg/dl increase in sCr, on mortality in sepsis, depends on how this sCr
increase is calculated. Only if the evolution of serum creatinine over the first 24 h after ICU admission is taken into
account, an association with mortality is found.
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Background
There is growing evidence that Acute Kidney Injury
(AKI) is an independent predictor of mortality rather
than an innocent bystander. In cardiac surgery it has
clearly been demonstrated that even small serum cre-
atinine (sCr) increases are associated with increased
mortality risk [1–4]. It remains unclear if this also ap-
plies to sepsis.
There is continuing debate on the interpretation of the
proposed AKI classification criteria [5–8], and several
interpretations of the same AKI definitions continue to
appear in the literature [9–12]. The most important
issue in this debate relates to the way we calculate the
sCr increase. The currently proposed practice to use the
highest creatinine value over a certain time span after
ICU (Intensive Care Unit) admission does not take into
account the evolution of sCr as a response to therapeutic
interventions. Although this might not be problematic
when "AKI" is used as a diagnostic classifier, it can have
an influence on the prognostic value of the label "AKI".
The prognostic value of AKI, using a 0.3 mg/dl cut off
value for sCr increase, as proposed by AKIN (Acute Kid-
ney Injury Network), KDIGO (Kidney Disease Improving
Global Outcomes) and ERBP (European Renal Best Prac-
tice) [5, 7, 8], has not previously been validated in a pro-
spective cohort of exclusively sepsis patients. These
patients are particularly prone to capillary leak and fluid
accumulation which influences the distribution volume
of sCr, potentially resulting in a delay in sCr increase
due to dilution [13]. This might result in even smaller* Correspondence: wim.vanbiesen@ugent.be
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increases of serum creatinine being associated with mor-
tality in sepsis.
We hypothesized that changing the way to calculate
serum creatinine increase could impact the prognostic
value of AKI. In this prospective cohort study, we evalu-
ated the impact of using three different algorithms to
calculate the sCr increase. One algorithm (ΔADM) took
into account the evolution of sCr by comparing the sCr
value 24 h after ICU admission with the ICU admission
value. The other two algorithms (ΔHIS and ΔEST) were
based on the peak sCr value over the same time span,
compared to either a historical baseline value (ΔHIS) or
an estimated baseline value (ΔEST). Additionally, we
intended to explore the robustness of a 0.3 mg/dl sCr in-
crease in sepsis, by comparing its predictive value to that
of either smaller or larger sCr increases. We hypothe-
sized that in sepsis, maybe even smaller serum creatinine
increases would be associated with mortality because of
dilution due to fluid accumulation.
Methods
One hundred and ninety five consecutive adult patients
(age ≥ 17 years) with sepsis admitted to the intensive
care unit (ICU) of the Ghent University Hospital be-
tween 12/01/2010 and 27/03/2011 were included in this
prospective cohort study. Sepsis, severe sepsis and septic
shock were defined according to the American College
of Chest Physicians/Society of Critical Care Medicine
Consensus Conference guidelines [14]. Exclusion criteria
were: 1) ICU stay less than 24 h or withdrawal of ther-
apy, 2) no bladder catheter, 3) patients treated with
chronic hemodialysis, 4) patients with RRT need due to
AKI upon ICU admission, 5) Age < 17 years, 6) a history
of organ transplantation, 7) obstructive AKI and 8) no
central line or arterial catheter. Survival status was
assessed at ICU, at 3 months, 1 year and 2 years by JV,
either by checking hospital records or by telephone
interview with the family practitioner.
Patients who developed sepsis during their ICU stay
were not considered for inclusion.
The study was approved by the ethical committee of
the Ghent University Hospital. Written informed con-
sent was obtained from the patient or their next of kin.
Three algorithms were used to calculate the sCr in-
crease: 1) “ΔHIS”, defined as the highest value within
24 h after ICU admission minus the value of a pre-
admission historical baseline; 2) “ΔEST”, defined as the
highest value 24 h after ICU admission minus an esti-
mated baseline value obtained by solving the MDRD
(Modification of Diet in Renal Disease) equation assum-
ing a GFR (Glomerular Filtration Ratio) of 75 ml/min/
1.73 m2, as suggested by ADQI [6] and 3) “ΔADM”, de-
fined as the value at 24 h after ICU admission minus the
value at ICU admission. We also used different values of
sCr increase as threshold for AKI diagnosis (0.1, 0.2, 0.3,
0.4, and 0.5 mg/dl), to assess the robustness of the
0.3 mg/dl sCr increase criterion in sepsis.
Blood samples for measuring sCr were collected at the
moment of study inclusion (D0T0), four hours later
(D0T4), the next morning at 6 AM (D1) and daily at
6 AM for the next four days. during the first five days
after ICU admission, centrifuged immediately and frozen
at −80° for later batch analysis, using an Isotope Dilution
Mass Spectroscopy traceable method (Roche Diagnos-
tics®). Once patients were on dialysis, serum creatinine
values within study protocol were no longer measured.
Severity of illness was assessed by the APACHE (Acute
Physiology and Chronic Health Evaluation) II score dur-
ing the first 24 h after admission, with or without the
renal score.
The 24 h fluid balance was registered for all patients
to account for bias due to fluid dilution.
All sepsis patients admitted to ICU between 6 AM
and 18 PM were included on the day of ICU admission.
Patients admitted to ICU after 18 PM were included the
following day at 6 AM. For all patients, ‘Day 1’ (D1 = the
day following the inclusion day) starts at 6 AM following
the day of inclusion. (Fig. 1) Since the time interval
between D1 and ICU admission was the same in each
individual patient for the three algorithms, this issue is
not likely to have influenced our results. The mean time
interval also approximates 24 h (mean = 26 h). Addition-
ally, if anything, having to deal with different time
intervals between patients would have lowered our
chances of demonstrating that including the evolution of
serum creatinine in the AKI definition enhances the
predictive performance of the label ‘AKI’, The latter
because in those patients with a time interval less than
24 h, there might not have been sufficient time to evalu-
ate the response to fluid resuscitation yet.
Statistical analysis
Results are reported as medians and interquartile ranges
(IQR) for continuous variables, unless otherwise speci-
fied. Discrete variables are reported as numbers and/
or percentages. All statistical analyses were performed
using SPSS® 19.
Chi square was used to asses a difference in prevalence
in case of a dichotomous outcome. Results are reported
as Odds ratio with 95 % confidence intervals (OR;
95 % CI). Student t test was used to compare the means of
normally distributed continuous variables whereas non
parametric tests were used to compare the medians of not
normally distributed continuous variables.
Logistic regression (3 months) and Cox regression
(1 and 2 year) were performed in forward and backward
mode, presenting age, gender, presence of pre-existing
renal insufficiency (eGFR <60 ml/min) (CKD (Chronic
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Kidney Disease)), APACHE II score, need for ventilation
and 24 h fluid balance to the model as potential predictors
for mortality. As additional parameter, AKI according to
the different algorithms (ΔHIS, ΔEST and ΔADM) and
with different cut-offs for sCr increase for each algorithm
(0.1, 0.2, 0.3, 0.4 and 0.5 mg/dl sCr increase) were added
to the model as a dummy code. Predictive performance
was also assessed by comparing AUC ROC (Area Under
the Curve of a Receiver Operating Characteristics Curve)
analysis of the different models.
For the short term (3 months) mortality, we used a lo-
gistic regression model whereas for 1 and 2 years sur-
vival, we considered survival time as a continuous
variable and used Cox Regression.
None of the patients was lost to follow-up. Two pa-
tients did not have a serum creatinine value available at
D1 because they had died by then; as a consequence the
ΔADM algorithm could not be used in these patients
(since it is based on the value at D1 minus the ICU ad-
mission value). Another 8 patients did not have a serum
creatinine value available at D1 because they were already
on RRT by that time. These patients all had a rise in
serum creatinine > 0.3 mg/dl before reaching the end of
the time interval (=the value at D1), so they were assumed
to have AKI according to the ΔADM algorithm although
no actual value at D1 was available to calculate the serum
creatinine increase. This paper complies with the STROBE
criteria (see Additional file 1).
Results
Descriptive patient data
In this study, 195 consecutive patients with sepsis, severe
sepsis and septic shock, were included. During the study
period, 253 patients were considered for inclusion of
whom 58 were excluded (18 for not having a bladder cath-
eter, 13 because of RRT need upon ICU admission, 10 with
a history of organ transplantation, 7 because of the deci-
sion to withdraw therapy, 5 for being treated with chronic
dialysis, 3 who had ICU stay < 24 h, 1 with obstructive AKI
and 1 who did not have an arterial or central venous line).
Nine (4.6 %), 63 (32.3 %) and 123 (63.1 %) had sepsis,
severe sepsis and septic shock, respectively. Overall mortal-
ity rates at the ICU, three months, 1 year and 2 years were
23.1 %, 31.3 %, 43.6 % and 50.3 %, respectively. Of the
patients who needed RRT during their ICU stay
(n = 27(13.8 %)), cumulative mortality rate during ICU stay
was 55.6 % (OR 5.75(2.44-13.53). Eighty-three percent of
patients who were treated with RRT and survived ICU
(n = 10/12), survived up to two years. One patient treated
with RRT died at three months and another died at year 1.
Demographics and relevant data for AKI vs no
AKI according to the three different definitions (ΔADM
> 0.3 mg/dl, ΔHIS > 0.3 mg/dl and ΔEST > 0.3 mg/dl) are
presented in Table 1.
The prevalence of AKI varied according to the definition
used. Based on ΔADM> 0.3 mg/dl vs ΔHIS > 0.3 mg/dl
and ΔEST > 0.3 mg/dl, 27(13.8 %) vs 98(50.3 %) and
89(45.6) patients were labelled as having AKI (p < 0.001).
(Table 1).
Patients classified in the AKI vs no AKI group accord-
ing to ΔADM > 0.3 mg/dl had a greater severity of illness
as demonstrated by a higher APACHE II score (p = 0.003),
a higher need for invasive ventilation (p < 0.001) and a
longer ICU stay (p = 0.009). When ΔHIS or ΔEST were
used, there was a difference in APACHE II score in AKI
vs no AKI but not in need for invasive ventilation or
Fig. 1 Illustration of the method used for study inclusion. a: Graphic presentation of the time interval between the sCr value at D1 and the ICU
admission value in case of a patient being admitted just after 18 pm. b: Graphic presentation of the time interval between the sCr value at D1
and the ICU admission value in case of a patient being admitted just before 18 pm
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length of ICU stay (Table 1). Based on ΔHIS or ΔEST,
there is a steady decrease in sCr vs the admission value in
the AKI group over the following four days, as opposed to
AKI according to ΔADM (Fig. 2a, b and c).
Influence on prognostic value of different algorithms to
calculate a serum creatinine increase of 0.3 mg/dl
Entire study cohort
In patients with AKI vs no AKI defined according to
ΔADM> 0.3 mg/dl, ICU mortality, and three months,
1 year and 2 years mortality rates were 44.4 %, 48.1 %,63 %
and 63 % vs 18.7 %, 27.7 %, 39.8 % and 47.6 %, respectively
(OR 3.48(1.48-8.18), 2.42(1.06-5.54), 2.58(1.11-5.97) and
1.87(0.81-4.33)) (Table 1 and Fig. 3a).
When AKI was defined according to ΔHIS > 0.3 mg/dl
or ΔEST > 0.3 mg/dl, mortality rates were not different
between AKI and no-AKI respectively at any of the time
points (Table 1 and Fig. 3a).
ICU survivors
In ICU survivors (n = 150), mortality rates at three
months, 1 year and 2 years in AKI vs no-AKI according
to ΔADM> 0.3 mg/dl were 6.7 %, 33.3 % and 33.3 % vs
11.9 %, 25.9 % and 35.6 % respectively (OR 0.53(0.07-4.32),
1.43(0.46-4.47) and 0.91(0.29-2.81) respectively). Based on
ΔHIS > 0.3 mg/dl, mortality rates were 9.6 %, 23.3 % and
30.1 % vs 13 %, 29.9 % and 40.3 % respectively (OR
0.71(0.26-1.98), 0.71(0.34-1.48) and 0.64(0.33-1.26)). Based
on ΔEST > 0.3 mg/dl these were 13.4 %, 28.4 % and 31.3 %
vs 9.6 %, 25.3 % and 38.6 % in AKI vs no AKI respectively
(OR 1.46(0.53-4.00), 1.17(0.57-2.42) and 0.73(0.37-1.44))
(Fig. 3b).
Thus with none of the above definitions (ΔADM >
0.3 mg/dl, ΔHIS > 0.3 mg/dl or ΔEST > 0.3 mg/dl) there
was a significant difference in mortality rates between
AKI and no AKI in septic patients who survived their
ICU stay, either at three months, 1 year and 2 years.
Also other variants of calculating ΔsCr were assessed,
which confirmed that in sepsis patients only the evolution
of sCr as compared to admission sCr was prognostic for
mortality (see Additional files 2, 3 and 4).
Prognostic value for mortality of different cut-off values
for serum creatinine increase
Using the different algorithms to calculate increase of
sCr (ΔADM, ΔHIS, ΔEST) and different cut-off levels
for that increase (0.1 mg/dl to 0.5 mg/dl with increments
of 0.1 mg/dl), we found that in univariate analysis an in-
crease in sCr of 0.3 mg/dl was the lowest robust cut-off
value that was still associated with mortality at three
months in the entire cohort (OR 2.42, 95 % CI 1.06-5.54),
but only if the difference in increase of sCr was based on
ΔADM (Fig. 4a). At year 1 and 2 an increase in sCr of
0.3 mg/dl was also the lowest robust cut-off for prediction
of mortality in the entire cohort, again only when the def-
inition is based on ΔADM (RR 2.11(1.24-3.6) and RR
Table 1 Demographics in AKI vs no-AKI according to different definitions
AKI definition ΔADM>
0.3
ΔHIS > 0.3 ΔEST > 0.3
AKI/noAKI (n/%) AKI (27/
13.8)
no AKI (166/
85.1)
p
value
AKI(98/
50.3)
no AKI (97/
49.7)
p
value
AKI (89/
45.6)
no AKI (106/
54.4)
p
value
%male 66.7 61.4 0.6 67.3 57.7 0.17 65.2 60.4 0.49
Age(y)(mean/sd) 66.2(10.7) 60.7(15.6) 0.08 62.6(14.1) 60.2(15.8) 0.28 65.1(13.5) 58.2(15.5) 0.001
APACHE II 27(9) 22(9) 0.003 25(8) 19(9) <0.001 25(8) 20(9) <0.001
Ventilation(n/%) 25/92.6 80/48.2 <0.001 59/60.2 47/48.5 0.10 55/61.8 51/48.1 0.06
CKD(n/%) 7/25.9 23/13.9 0.11 18/18.4 12/12.4 0.25 25/28.1 5/4.7 <0.001
ICU admission serum creatinine
(mg/dl)
1.29(0.66) 1.05(0.89) 0.01 1.67(1.25) 0.79(0.40) <0.001 1.76(1.24) 0.80(0.39) <0.001
Historical baseline creatinine (mg/
dl)
0.98(0.41) 0.83(0.32) 0.18 0.88(0.37) 0.82(0.34) 0.52 0.98(0.35) 0.79(0.32) 0.001
RRT need(n/%) 14/51.9 13/7.8 <0.001 23/23.5 4/4.1 <0.001 24/27 3/2.8 <0.001
ICU LOS(d) in ICU survivors 15(22) 6(8) 0.009 6(9) 5(10) 0.34 7(9) 6(9) 0.24
ICU Mort(n/%) 12/44.4 31/18.7 0.003 25/25.5 20/20.6 0.42 22/24.7 23/21.7 0.62
Mort at three months(n/%) 13/48.1 46/27.7 0.03 32/32.7 29/39.9 0.68 30/33.7 31/29.2 0.50
Mort at 1 year(n/%) 17/63 66/39.8 0.024 42/42.9 43/44.3 0.84 41/46.1 44/41.5 0.52
Mort at 2 years(n/%) 17/63 79/47.6 0.14 47/48 51/52.6 0.52 46/48.3 51/51.9 0.62
AKI Acute kidney injury, ΔADM > 0.3 = Serum creatinine increase > 0.3 mg/dl based on the difference between the value 24 h after admission and ICU admission,
ΔHIS > 0.3 = Serum creatinine increase > 0.3 mg/dl based on the difference between the highest value during the first 24 h after ICU admission and a historical
baseline value, ΔEST > 0.3 = Serum creatinine increase > 0.3 mg/dl based on the difference between the highest value during the first 24 h after ICU admission and
an estimated baseline value, APACHE II Acute physiology and chronic health evaluation II score, CKD Chronic kidney disease, RRT Renal replacement therapy, ICU
LOS Intensive care unit length of stay, Mort Mortality
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1.79(1.06-3.03) for mortality at 1 year and 2 years respect-
ively) (Fig. 4b and c). In multivariate analysis adjusting for
the 24 h fluid balance, a 0.3 mg/dl increase in sCr
remained the lowest robust value that was associated with
mortality.
Multivariate analysis for prediction of mortality
In a logistic regression model adjusted, besides fluid bal-
ance, for age and gender, APACHE II score (OR per
point: 1.07, 95 % CI 1.02-1.13) and Need for Ventilation
(OR 3.29, 95 % CI 1.55-6.98) but not AKI according to
ΔADM, were independent predictors for mortality at
three months (Table 2). Comparable results were ob-
tained when the other definitions of AKI were used
(Table 2). Using the APACHE II score without the renal
score did not change these findings.
AUC ROC analysis confirmed that ΔADM> 0.3 mg/dl
did not add discriminatory value above APACHE II score
and Need for Ventilation for prognostication of mortality
at 3 months (AUC 0.71 without ΔADM> 0.3 mg/dl and
AUC 0.71 with ΔADM> 0.3 mg/dl).
In a Cox regression multivariate model applied to ICU
survivors, only age was an independent predictor for
mortality both at 1 year (RR = 1.04, 95 % CI: 1.01-1.07)
and 2 years (RR = 1.02, 95 % CI: 1.002-1.045) (Table 3).
This suggests that longer term mortality in sepsis pa-
tients is more influenced by underlying comorbidity
such as older age than by AKI or other parameters of
acute severity of illness.
Discussion
This study demonstrates that the predictive value of an
increase in serum creatinine of 0.3 mg/dl, on mortality
AKI according to ADM>0.3
BA
C
AKI according to HIS>0.3
AKI according to EST>0.3
p=0.18 p<0.001
p<0.001
Fig. 2 Evolution of serum creatinine over 4 days in patients with Acute Kidney Injury (AKI), according to different algorithms. As opposed to
Acute Kidney Injury based on ΔADM > 0.3 mg/dl (a), there is a steady decrease in serum creatinine after admission over the following four days
when AKI is defined according to ΔHIS > 0.3 mg/dl (b) or ΔEST > 0.3 mg/dl (c)
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in sepsis, depends on how this sCr increase is calculated.
Only if the evolution of sCr after ICU admission, rather
than a peak sCr value over the same time span, is taken
into account, an association with mortality is found. An
increase in sCr of 0.3 mg/dl according to the ICU ad-
mission value is the lowest robust value still associated
with mortality, confirming previous data in the cardiac
surgery setting. This 0.3 mg/dl cut off remained robust
even after adjustment for 24 h fluid balance. However,
after adjusting for severity of illness, a sCr increase of
0.3 mg/dl was no longer associated with mortality.
Although the definition of AKI has become progres-
sively more uniform since the introduction of RIFLE [6],
uncertainty and debate on the methodology to calculate
B
A
Fig. 3 Mortality rates (%) in Acute Kidney Injury (AKI) vs no Acute Kidney Injury according to different algorithms, in the entire cohort and in ICU
survivors separately. a: Mortality rates at ICU, 3 months, 1 year and 2 years in the entire cohort in AKI vs no AKI, either based on ΔADM> 0.3 mg/dl,
ΔHIS > 0.3 mg/dl or ΔEST > 0.3 mg/dl. Only based on ΔADM> 0.3 mg/dl, there is a higher mortality at ICU, 3 months and 1 year in AKI vs no AKI. At year
2, there is no significant different in mortality between AKI and no AKI with either of the algorithms. b: Mortality rates at 3 months, 1 year and 2 years in
ICU survivors in AKI vs no AKI, either based on ΔADM> 0.3 mg/dl, ΔHIS > 0.3 mg/dl or ΔEST > 0.3 mg/dl. There is no significant difference in mortality
between AKI and no AKI at the three time points, independent of the algorithm used
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the sCr increase remains, and different interpretations
are still appearing in the literature [9–12].
Most guidelines advocate to use the difference between
the highest sCr value over a certain time span, and a pre
admission historical baseline value [15, 16] or an esti-
mated sCr value by solving the MDRD formula assuming
a GFR of 75 ml/min/1,73 m2 [17–20]. It has been demon-
strated that the use of surrogate baseline sCr values can
lead to misclassification by either under- or overesti-
mation of AKI [15]. Siew et al. investigated the impact of
using different surrogate baseline values in a large cohort
of 4863 adults, on AKI diagnosis and outcome [16]. As in
our cohort, they found that the incidence of AKI de-
creased by using the ICU admission sCr value as baseline
versus a pre admission historical sCr value. They also
demonstrated that mortality rates were different according
to which surrogate value was used [16]. As in our study,
mortality rates were highest when AKI was defined ac-
cording to the admission value. However, Siew et al. used
a cohort containing mainly non-critically ill patients (only
19 % of patients were admitted to ICU) and only in-
hospital and 60 days mortality were evaluated, without ad-
justment for severity of illness [16].
The strategy of using the peak sCr value over a certain
time span after admission does not allow to study the
impact of the evolution of sCr after starting therapeutic
interventions such as fluid resuscitation. In our cohort,
AKI was associated with mortality, but only if based on
the difference between the value 24 h after admission
and the value at ICU admission and not if based on the
peak value over the same time span compared to a his-
torical or estimated baseline value. These findings sug-
gest that the evolution of sCr in the first 24 h after ICU
admission, and thus the potential response to fluid re-
suscitation, is most predictive for outcome which is in
line with previous observations [21]. By taking into ac-
count the evolution of serum creatinine after ICU ad-
mission, those patients who experience a decrease in
Fig. 4 Odds ratio of incremental cut-off values for serum creatinine increase and mortality in the entire cohort. A 0.3 mg/dl increase in serum creatinine is
the lowest robust cut-off value associated with 3 months mortality (a), but only if this increase is based on ΔADM> 0.3 mg/dl (OR 2.42(1.06-5.54). At year
1 (b) and year 2 (c), a serum creatinine increase of 0.3 mg/dl is also the lowest robust cut-off value associated with mortality but again only if this increase
is based on ΔADM> 0.3 mg/dl (RR 2.11(1.24-3.6) and RR 1.79(1.06-3.03) at year 1 and year 2 respectively)
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Table 2 Multivariate logistic regression for prediction of mortality at three months including different AKI definitions in the model
Exp(B) 95 % CI p value
ΔADM > 0.3 1.36 0.53-3.51 0.53
Age 1.01 0.99-1.04 0.28
Gender 0.75 0.37-1.47 0.39
APACHE II 1.07 1.02-1.13 0.009
Need for Ventilation 3.29 1.55-6.98 0.002
Fluid balance over the first 24 h after ICU admission 0.89 0.76-1.05 0.17
ΔHIS > 0.3 0.64 0.31-1.32 0.23
Age 1.01 0.99-1.04 0.35
Gender 0.68 0.34-1.35 0.27
APACHE II 1.09 1.03-1.15 0.002
Need for Ventilation 3.32 1.60-6.89 0.001
Fluid balance over the first 24 h after ICU admission 0.92 0.79-1.07 0.28
ΔEST > 0.3 0.66 0.32-1.36 0.26
Age 1.01 0.99-1.04 0.26
Gender 0.69 0.35-1.38 0.29
APACHE II 1.09 1.03-1.15 0.002
Need for Ventilation 3.32 1.60-6.87 0.001
Fluid balance over the first 24 h after ICU admission 0.92 0.78-1.07 0.27
ΔADM > 0.3 = Serum creatinine increase > 0.3 mg/dl based on the difference between the value 24 h after admission and ICU admission, APACHE II Acute
physiology and chronic health evaluation II score, ICU Intensive care unit, ΔHIS > 0.3 = Serum creatinine increase > 0.3 mg/dl based on the difference between the
highest value during the first 24 h after ICU admission and a historical baseline value, ΔEST > 0.3 = Serum creatinine increase > 0.3 mg/dl based on the difference
between the highest value during the first 24 h after ICU admission and an estimated baseline value
Table 3 Multivariate cox regression analysis for prediction of mortality at 1 year and 2 years in ICU survivors
1 year mortality in ICU survivors Exp(B) 95 % CI p value
Age 1.04 1.01-1.07 0.004
Creatinine day 1 0.69 0.38-1.26 0.23
CKD 1.66 0.70-3.94 0.26
ΔADM > 0.3 1.60 0.48-5.31 0.44
Need for Ventilation 1.16 0.59-2.29 0.67
Gender 0.65 0.32-1.31 0.23
APACHE II 1.01 0.96-1.07 0.59
Fluid balance over the first 24 h after ICU admission 0.91 0.76-1.09 0.28
2 years mortality in ICU survivors
Age 1.02 1.002-1.045 0.03
Creatinine day 1 0.48 0.26-0.86 0.01
CKD 2.06 0.94-4.48 0.07
ΔADM > 0.3 1.35 0.43-4.25 0.61
Need for Ventilation 1.44 0.79-2.60 0.23
Gender 0.68 0.37-1.24 0.20
APACHE II 1.04 0.99-1.08 0.10
Fluid balance over the first 24 h after ICU admission 0.91 0.78-1.06 0.21
ICU Intensive care unit, CKD Chronic kidney disease, ΔADM > 0.3 = Serum creatinine increase > 0.3 mg/dl based on the difference between the value 24 h after
admission and ICU admission, APACHE II Acute physiology and chronic health evaluation II score
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serum creatinine under fluid resuscitation are no longer
classified as having AKI which translates in a lower
number of AKI cases compared to using the peak serum
creatinine value over the same time period. It allows us
to differentiate patients who are generally sicker and
have more severe AKI and hence a worse outcome,
from those with less severe AKI, responding to fluid
resuscitation.
It is generally accepted that AKI is associated with in-
creased mortality [22–24]. Bagshaw et al. performed a
retrospective interrogation of prospectively included pa-
tients with sepsis, septic AKI and non-septic AKI. Sepsis,
septic AKI and non-septic AKI were all found to be sig-
nificantly associated with poor outcome. However, au-
thors only looked at short term mortality (28 days and
hospital mortality) and no data on RRT need were avail-
able, so it is unclear whether the effect on mortality was
mainly driven by RRT need [23].
Despite this generally accepted association between
AKI and mortality, the topic is still also a matter of de-
bate, even in the non-critically ill. In a population based
study of AKI, no association between AKI and outcome
was found [25]. A higher risk for chronic dialysis need,
but not mortality, was found in a large cohort of ICU
survivors [26]. However, several reports indicated that
the duration of AKI is highly predictive of mortality
[27], an aspect that was not evaluated in the current
study. This might explain why in our cohort the diagno-
sis of AKI was no longer independently associated with
mortality after adjustment for severity of illness. Our
data indicate that the response to treatment in the first
24 h after ICU admission also influences prognosis,
probably by unveiling those who positively respond to
volume resuscitation. Several older and more recent
studies also demonstrated that the most important pre-
dictors for mortality were already present at admission
to the ICU and included advanced age, the presence of
infection, a past history of chronic diseases and the pres-
ence of other failing organs [28–32].
Although recent literature shows that even small in-
creases in sCr are independently associated with mortal-
ity, these results are mainly obtained in cohorts of
cardiac surgery patients, after coronarography and after
myocardial infarction [1–4, 33–35]., In cardiac surgery,
the relation between small increases in sCr and mortality
might be amplified by the observation that in patients
without AKI, sCr levels are expected to decrease in the
first 24 h after surgery because of fluid loading perio-
peratively, diluting the sCr value [36]. The association
between small increases in sCr and poor outcome can-
not necessarily be extrapolated to other conditions, such
as sepsis. Sepsis patients are particularly vulnerable to
capillary leak and fluid accumulation. Thus theoretically
even smaller increases of sCr could be associated with
mortality because of dilution of sCr, and a delay in diag-
nosis [13]. However, according to the results of the
current study, even after adjustment for 24 h fluid bal-
ance, a 0.3 mg/dl increase in sCr 24 h after ICU admis-
sion compared to the ICU admission value, seems to
be the lowest robust threshold for increased risk in
sepsis patients.
The strong points of this prospective study are the
availability of longer term outcomes and the detailed pa-
tient information.
Our study is the first to consider that the evolution of
sCr after start of therapy, rather than an absolute highest
value over a certain time span is important with regard
to outcome.
A limitation of this study is its observational nature
and the fact that it is a single centre study describing a
relatively small cohort of patients which enhances the
chance of a type 2 error. We acknowledge that our re-
sults need to be validated in a larger cohort and are not
necessarily generalizable to sepsis cohorts including pa-
tients with different severity of illness. However, the
finding that taking into account the evolution of serum
creatinine demonstrates a better association with mortal-
ity compared to only relying on a peak serum creatinine
value over a certain time span for AKI diagnosis, does
make sense from a pathophysiological point of view.
Taking into account the evolution of serum creatinine
allows for the identification of those who have more
sever AKI, are more ill and consequently have a worse
outcome.
By capturing AKI during the first 24 h after ICU ad-
mission we could incorporate the early response to fluid
resuscitation in the ΔADM algorithm. Although by
doing so we missed the AKI cases occurring after 24 h
this is not likely to change our general message that AKI
classification criteria should incorporate the evolution of
sCr in response to fluid resuscitation. Also when we
used a 48 h interval, our findings did not change (see
Additional files 2, 3 and 4).
We did not include the urinary output as a prognostic
criterion in this study. We demonstrated before that tak-
ing into account urinary output improved the diagnostic
performance of RIFLE [37]. In several other studies, it
was demonstrated that urinary output is associated with
mortality in the critically ill [38, 39]. In the current
study, however, we wanted to evaluate the independent
impact a change in the sCr criterion, as this is the most
widely used criterion for prognostic modelling, especially
in large (administrative) database cohorts [35, 40, 41].
Mortality rates in our cohort are low compared to
what was reported in a recent study [42]. However, in
general, mortality rates in sepsis have been reported to
decline [42–45]. Mortality rates in our cohort of patients
with sepsis might also be lower than in previous reports
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because we have a very good system in place in our ICU to
alert physicians of pending AKI. Most of these alerts are
induced by reduced urinary output [46]. It has been dem-
onstrated before that AKI defined by oliguria has a better
prognosis as AKI defined by the creatinine criterion [24].
Conclusion
The prognostic value of a 0.3 mg/dl increase in sCr, on
mortality in sepsis, depends on the algorithm to calculate
this sCr increase. Only if the evolution of serum creatinine
over the first 24 h after ICU admission is taken into ac-
count, an association with mortality is found. This 0.3 mg/
dl increase criterion remains robust, even after adjusting
for 24 fluid balance. After adjustment for severity of ill-
ness, a sCr increase of 0.3 mg/dl is no longer associated
with mortality in sepsis.
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